Greenwich Lifesciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $5 | $0 |
Gross Profit | ||||
EBITDA | -2,728 | -2,660 | -2,536 | |
EBIT | -2,729 | -2,661 | -2,537 | |
Net Income | -2,668 | -2,606 | -2,473 | -2,746 |
Net Change In Cash | 0 | 0 | 5 | 0 |
Free Cash Flow | -2,583 | -1,047 | -1,782 | -2,154 |
Cash | 5,822 | 7,224 | 5,505 | 6,989 |
Basic Shares | 13,142 | 12,906 | 12,859 | 12,848 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -3 | -3 | -3 | -3 |
EBITDA | -9,324 | -8,036 | -4,594 | -1,860 |
EBIT | -9,327 | -8,040 | -4,597 | -1,863 |
Net Income | -8,891 | -7,610 | -4,543 | -1,862 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -1,456 | 28,653 | ||
Free Cash Flow | -6,478 | -6,200 | -4,291 | -1,152 |
Cash | 6,989 | 13,468 | 27,204 | 28,660 |
Basic Shares | 12,848 | 12,913 | 12,944 | 12,703 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.20 |
2024-06-30 | -$0.20 |
2024-03-31 | -$0.19 |
2023-12-31 | -$0.21 |
